Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
More Than Half of U.S. Adults Could Be Candidates for Ozempic
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Sold as
Why Alarm Is Easing Over a Rise in Pancreatic Cancer Among the Young
Experts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases has not been accompanied by any inc
Judge Declares Wyoming's Abortion Bans Unconstitutional
Two Wyoming abortion bans, including the first state law to prohibit the use of abortion pills, violate the state s constitution, a judge ruled Monday. In her d
Icotrokinra Delivered an Industry-Leading Combination of Significant Skin Clearance with Demonstrated Tolerability in a Once Daily Pill in Phase 3 Topline Results
SPRING HOUSE, Pa. (November 18, 2024) Johnson Johnson (NYSE JNJ) today announced positive topline results from ICONIC-LEADa, a pivotal Phase 3 investigational s
Gabapentinoid Use Tied to Higher Risk for Hip Fractures
Gabapentinoid use is associated with an increased risk for hip fractures, according to a study published online Nov. 13 in JAMA Network Open.Miriam T.Y. Leung,
Metformin Use Tied to Lower Rate of Asthma Attacks
Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published online Nov. 18 in JAMA Internal Medicine.
Primary Care Encounter Notes Often Lack Thoroughness
Physician electronic health record (EHR) notes of primary care patient encounters often lack thoroughness, according to a study recently published online in BMC
Transcranial Direct Current Stimulation Safe, Effective for Tardive Dyskinesia
Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in
Global Coverage With Measles Vaccine Declined During COVID-19
Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023, ac
Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
PASADENA, Calif. (BUSINESS WIRE) Nov. 18, 2024 Arrowhead Pharmaceuticals, Inc. (NASDAQ ARWR) today announced new results from the Phase 3 PALISADE study and the
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions